Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Merck partners with Quartet Medicine in pain; gains option to buy company

Executive Summary

Merck & Co. Inc. is partnering with translational medicine start-up Quartet Medicine Inc. to develop drugs for chronic pain from Quartet's pipeline of small-molecule compounds that modulate the tetrahydrobiopterin (BH4) pathway.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes M&A Option
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register